<DOC>
	<DOCNO>NCT02783053</DOCNO>
	<brief_summary>Metformin known increase 18F-FDG uptake subject use metformin retrospective trial . In study researcher aim investigate influence metformin ( 500 mg 1/day ) temperature colon , glucose uptake colon energy expenditure healthy lean ( BMI &lt; 24kg/m2 ) obese subject ( BMI &gt; 28kg/m2 ) . The investigator measure 18F-FDG uptake colon , temperature colon , insulin sensitivity energy expenditure use metformin .</brief_summary>
	<brief_title>Metformin Core Temperature Obese Lean Males</brief_title>
	<detailed_description>Obesity diabetes mellitus type 2 ( DM2 ) health problem tremendous impact . Many attempt make combat obesity DM2 , however , breakthrough therapy still lack . Obesity result imbalance energy intake energy expenditure . 18F-fluorodeoxy-d-glucose ( 18F-FDG ) positron emission tomography compute tomography ( PET-CT ) pinpoint area high glucose turnover . Physiological 18F-FDG accumulation frequently observe colon . Therefore , colon might play important role increase energy expenditure consume calorie . However , possibility colon energy dissipate tissue yet explore . The colon could become interesting new target research find method combat obesity . Metformin one drug treatment DM2 associate moderate weight loss . Interestingly , patient use metformin show increase 18F-FDG-uptake colon . Whether high uptake glucose also cause increase core temperature and/or increase energy expenditure know . The cause increase glucose uptake colon metformin use unknown . Also , unknown whether increase glucose uptake result increase energy expenditure and/or increase core body temperature . Objective : In study researcher aim investigate influence metformin ( 500 mg 1/day ) temperature colon , glucose uptake colon energy expenditure healthy lean ( BMI &lt; 24kg/m2 ) obese subject ( BMI &gt; 28kg/m2 ) . The investigator measure 18F-FDG uptake colon , temperature colon , insulin sensitivity energy expenditure use metformin .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<criteria>Male Caucasian origin Subjects able willing give inform consent &gt; 50 year old BMI &lt; 24 kg/m2 &gt; 28 kg/m2 Renal failure ( GFR &lt; 60ml/min ) Liver insufficiency ( AST alanine aminotransferase 3 time upper value ) Chronic use drug medication Diabetes mellitus Lactate acidosis precoma diabeticum medical history Acute chronic disease : dehydration , severe infection , shock , heartfailure , pulmonary insufficiency , recent heart attack Alcoholism</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>